NQMC Update Service: July 18, 2016 || Centers for Medicare & Medicaid Services

NQMC Update Service: July 18, 2016

Centers for Medicare & Medicaid Services

• End stage renal disease (ESRD): percentage of adult dialysis patients with a 3-month rolling average of total uncorrected calcium (serum or plasma) greater than 10.2 mg/dL (hypercalcemia). This updates a previously published measure summary.
• End stage renal disease (ESRD): percentage of all patient months for adult patients (≥ 18 years old) whose delivered dose of hemodialysis (calculated from the last measurement of the month using the UKM or Daugirdas II formula) was spKt/V ≥ 1.2. This updates a previously published measure summary.
• End stage renal disease (ESRD): percentage of all patient months for adult patients (≥ 18) whose delivered peritoneal dialysis dose was a weekly Kt/Vurea ≥ 1.7 (dialytic + residual). This updates a previously published measure summary.
• End stage renal disease (ESRD): percentage of patient months for all pediatric (< 18 years old) in-center hemodialysis patients in which the delivered dose of hemodialysis (calculated from the last measurement of the month using the UKM or Daugirdas II formula) was spKt/V ≥ 1.2. This updates a previously published measure summary.
• End stage renal disease (ESRD): percentage of patient months for patients on maintenance hemodialysis during the last HD treatment of month using an autogenous AV fistula. This updates a previously published measure summary.
• End stage renal disease (ESRD): percentage of patient months on maintenance hemodialysis during the last HD treatment of month with a chronic catheter continuously for 90 days or longer prior to the last hemodialysis session. This updates a previously published measure summary.